Conformational constraints for amyloid fibrillation: the importance of being unfolded.
暂无分享,去创建一个
[1] M. Schiffer,et al. Physicochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chains , 2008, Protein science : a publication of the Protein Society.
[2] Vladimir N Uversky,et al. A Protein-Chameleon: Conformational Plasticity of α-Synuclein, a Disordered Protein Involved in Neurodegenerative Disorders , 2003, Journal of biomolecular structure & dynamics.
[3] V. Uversky,et al. Partially folded intermediates in insulin fibrillation. , 2003, Biochemistry.
[4] Giampaolo Merlini,et al. Molecular mechanisms of amyloidosis. , 2003, The New England journal of medicine.
[5] S. Radford,et al. A systematic investigation into the effect of protein destabilisation on beta 2-microglobulin amyloid formation. , 2003, Journal of molecular biology.
[6] C. Yu,et al. Amyloid-like fibril formation in an all beta-barrel protein. Partially structured intermediate state(s) is a precursor for fibril formation. , 2003, The Journal of biological chemistry.
[7] V. Uversky,et al. Nitration inhibits fibrillation of human α‐synuclein in vitro by formation of soluble oligomers , 2003 .
[8] Theodore W Randolph,et al. Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony‐stimulating factor , 2003, Protein science : a publication of the Protein Society.
[9] Yuji Goto,et al. Amyloidogenic synthetic peptides of beta2-microglobulin--a role of the disulfide bond. , 2003, Biochemical and biophysical research communications.
[10] R. L. Baldwin,et al. Role of backbone solvation and electrostatics in generating preferred peptide backbone conformations: Distributions of phi , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[11] C. Weston,et al. Prevention of peptide fibril formation in an aqueous environment by mutation of a single residue to Aib. , 2003, Biochemistry.
[12] R. Ribeiro,et al. Reversible amyloid formation by the p53 tetramerization domain and a cancer-associated mutant. , 2003, Journal of molecular biology.
[13] C. Masters,et al. Diverse fibrillar peptides directly bind the Alzheimer’s amyloid precursor protein and amyloid precursor-like protein 2 resulting in cellular accumulation , 2003, Brain Research.
[14] T. Koga,et al. Structural regulation of a peptide-conjugated graft copolymer: a simple model for amyloid formation. , 2003, Chemistry.
[15] P. Fraser,et al. Identification of minimal peptide sequences in the (8-20) domain of human islet amyloid polypeptide involved in fibrillogenesis. , 2003, Journal of structural biology.
[16] H. Nakanishi,et al. Effect of pH on the aggregate formation of a non‐amyloid component (1–13) , 2003, Journal of peptide science : an official publication of the European Peptide Society.
[17] V. Uversky,et al. Conformational behavior and aggregation of alpha-synuclein in organic solvents: modeling the effects of membranes. , 2003, Biochemistry.
[18] J. Kelly,et al. Prevention of Transthyretin Amyloid Disease by Changing Protein Misfolding Energetics , 2003, Science.
[19] J. Torres,et al. Conformational Switching and Fibrillogenesis in the Amyloidogenic Fragment of Apolipoprotein A-I* , 2003, The Journal of Biological Chemistry.
[20] C. Dobson,et al. In vitro characterization of lactoferrin aggregation and amyloid formation. , 2003, Biochemistry.
[21] Robert G Griffin,et al. Molecular conformation of a peptide fragment of transthyretin in an amyloid fibril , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[22] G. Howlett,et al. Cross-linking and amyloid formation by N- and C-terminal cysteine derivatives of human apolipoprotein C-II. , 2002, Biochemistry.
[23] H. Nakanishi,et al. pH-dependent aggregate forms and conformation of Alzheimer amyloid beta-peptide (12-24). , 2002, Journal of biochemistry.
[24] Andreas Hoenger,et al. De novo designed peptide-based amyloid fibrils , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[25] D. Vaux,et al. Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide. , 2002, Biochemistry.
[26] L. Tjernberg,et al. Charge Attraction and β Propensity Are Necessary for Amyloid Fibril Formation from Tetrapeptides* , 2002, The Journal of Biological Chemistry.
[27] À. Argilés,et al. BIGH3 (TGFBI) Arg124 mutations influence the amyloid conversion of related peptides in vitro. , 2002, European journal of biochemistry.
[28] Christopher M Dobson,et al. The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation , 2002, The EMBO journal.
[29] L. Iakoucheva,et al. Intrinsic disorder in cell-signaling and cancer-associated proteins. , 2002, Journal of molecular biology.
[30] H. Kleinman,et al. Ile‐Lys‐Val‐Ala‐Val (IKVAV)‐containing laminin α1 chain peptides form amyloid‐like fibrils , 2002, FEBS letters.
[31] Lynne Regan,et al. Does the location of a mutation determine the ability to form amyloid fibrils? , 2002, Journal of molecular biology.
[32] N. Lockwood,et al. Aqueous gel formation of a synthetic peptide derived from the beta-sheet domain of platelet factor-4. , 2002, Biomacromolecules.
[33] H. E. Stanley,et al. Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[34] C. Dobson,et al. Stimulation and inhibition of fibril formation by a peptide in the presence of different concentrations of SDS , 2002, FEBS letters.
[35] P. Lansbury,et al. Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. , 2002, Journal of molecular biology.
[36] P. Tompa. Intrinsically unstructured proteins. , 2002, Trends in biochemical sciences.
[37] G. Rose,et al. A simple model for polyproline II structure in unfolded states of alanine‐based peptides , 2002, Protein science : a publication of the Protein Society.
[38] Kiowa S. Bower,et al. Synergistic effects of pesticides and metals on the fibrillation of alpha-synuclein: implications for Parkinson's disease. , 2002, Neurotoxicology.
[39] Vladimir N Uversky,et al. Conformational behavior of human alpha-synuclein is modulated by familial Parkinson's disease point mutations A30P and A53T. , 2002, Neurotoxicology.
[40] C. Dobson,et al. A kinetic study of β‐lactoglobulin amyloid fibril formation promoted by urea , 2002 .
[41] V. Uversky,et al. Conformational Prerequisites for α-Lactalbumin Fibrillation† , 2002 .
[42] Meital Reches,et al. Amyloid Fibril Formation by Pentapeptide and Tetrapeptide Fragments of Human Calcitonin* , 2002, The Journal of Biological Chemistry.
[43] P. Nandi,et al. DNA-induced partial unfolding of prion protein leads to its polymerisation to amyloid. , 2002, Journal of molecular biology.
[44] D. Kirschner,et al. Molecular organization of amyloid protofilament-like assembly of betabellin 15D: helical array of beta-sandwiches. , 2002, Biophysical journal.
[45] Karin Romisch. Faculty Opinions recommendation of Neurodegenerative disease: amyloid pores from pathogenic mutations. , 2002 .
[46] Ž. Eva. Amyloid-fibril formation: Proposed mechanisms and relevance to conformational disease , 2002 .
[47] George D Rose,et al. Polyproline II structure in a sequence of seven alanine residues , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[48] Nancy A. Jenkins,et al. Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[49] S. Radford,et al. The yeast prion Ure2p retains its native α‐helical conformation upon assembly into protein fibrils in vitro , 2002, The EMBO journal.
[50] K. Hasegawa,et al. Conformation of β2-Microglobulin Amyloid Fibrils Analyzed by Reduction of the Disulfide Bond* , 2002, The Journal of Biological Chemistry.
[51] Ronald Wetzel,et al. Amyloid-like features of polyglutamine aggregates and their assembly kinetics. , 2002, Biochemistry.
[52] H. M. Petrassi,et al. Screening transthyretin amyloid fibril inhibitors: characterization of novel multiprotein, multiligand complexes by mass spectrometry. , 2002, Structure.
[53] Mark R. Wilson,et al. Suppression of apolipoprotein C-II amyloid formation by the extracellular chaperone, clusterin. , 2002, European journal of biochemistry.
[54] C. Dobson. Protein folding and its links with human disease. , 2002, Biochemical Society symposium.
[55] C. Yu,et al. Amyloid-like Fibril Formation in an All β-Barrel Protein Involves the Formation of Partially Structured Intermediate(s)* , 2002, The Journal of Biological Chemistry.
[56] J. Trojanowski,et al. Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein , 2002, Neuron.
[57] V. Subramaniam,et al. Amyloid fibrils from the mammalian protein prothymosin α , 2002 .
[58] V. Uversky,et al. Methionine oxidation inhibits fibrillation of human α‐synuclein in vitro , 2002 .
[59] M. Perutz,et al. Aggregation of proteins with expanded glutamine and alanine repeats of the glutamine-rich and asparagine-rich domains of Sup35 and of the amyloid β-peptide of amyloid plaques , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[60] V. Uversky,et al. Effect of Association State and Conformational Stability on the Kinetics of Immunoglobulin Light Chain Amyloid Fibril Formation at Physiological pH* , 2002, The Journal of Biological Chemistry.
[61] V. Uversky,et al. Elucidation of the Molecular Mechanism during the Early Events in Immunoglobulin Light Chain Amyloid Fibrillation , 2002, The Journal of Biological Chemistry.
[62] V. Uversky. Natively unfolded proteins: A point where biology waits for physics , 2002, Protein science : a publication of the Protein Society.
[63] B. Sivakumar,et al. Inhibition of transthyretin amyloid fibril formation by 2,4-dinitrophenol through tetramer stabilization. , 2002, Archives of biochemistry and biophysics.
[64] Kiowa S. Bower,et al. Accelerated α‐synuclein fibrillation in crowded milieu , 2002 .
[65] Eliah Aronoff-Spencer,et al. Molecular features of the copper binding sites in the octarepeat domain of the prion protein. , 2002, Biochemistry.
[66] P. Lansbury,et al. Molecular crowding accelerates fibrillization of alpha-synuclein: could an increase in the cytoplasmic protein concentration induce Parkinson's disease? , 2002, Biochemistry.
[67] A. Minton,et al. Macromolecular Crowding Accelerates Amyloid Formation by Human Apolipoprotein C-II* , 2002, The Journal of Biological Chemistry.
[68] G. Howlett,et al. The structural basis for amyloid formation by plasma apolipoproteins: a review , 2002, European Biophysics Journal.
[69] H. Dyson,et al. Coupling of folding and binding for unstructured proteins. , 2002, Current opinion in structural biology.
[70] V. Uversky,et al. Native-like secondary structure of molten globules. , 2002, Biochimica et biophysica acta.
[71] V. Turk,et al. Human stefin B readily forms amyloid fibrils in vitro. , 2002, Biochimica et biophysica acta.
[72] A. Dubnovitsky,et al. Amyloid fibril formation of the mouse V(L) domain at acidic pH. , 2002, Biochemistry.
[73] V. Uversky,et al. The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice , 2002, The Journal of Biological Chemistry.
[74] J. Kelly,et al. Synthesis, structure, and activity of diclofenac analogues as transthyretin amyloid fibril formation inhibitors. , 2002, Journal of medicinal chemistry.
[75] M G Fried,et al. Host-guest study of left-handed polyproline II helix formation. , 2001, Biochemistry.
[76] C. Dobson,et al. Solution conditions can promote formation of either amyloid protofilaments or mature fibrils from the HypF N‐terminal domain , 2001, Protein science : a publication of the Protein Society.
[77] V. Uversky,et al. Trimethylamine‐N‐oxide‐induced folding of α‐synuclein , 2001 .
[78] A. Clark,et al. Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology. , 2001, Biochimica et biophysica acta.
[79] V. Uversky,et al. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. , 2001, The Journal of biological chemistry.
[80] S. Lindquist,et al. The role of conformational flexibility in prion propagation and maintenance for Sup35p , 2001, Nature Structural Biology.
[81] M. Kirkitadze,et al. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. , 2001, Journal of molecular biology.
[82] B. Lin,et al. The mechanism of oxidation-induced low-density lipoprotein aggregation: an analogy to colloidal aggregation and beyond? , 2001, Biophysical journal.
[83] C. Link,et al. Transgenic invertebrate models of age-associated neurodegenerative diseases , 2001, Mechanisms of Ageing and Development.
[84] J. Kelly,et al. Anion shielding of electrostatic repulsions in transthyretin modulates stability and amyloidosis: insight into the chaotrope unfolding dichotomy. , 2001, Biochemistry.
[85] J. Carver,et al. The Molecular Chaperone, α-Crystallin, Inhibits Amyloid Formation by Apolipoprotein C-II* , 2001, The Journal of Biological Chemistry.
[86] N. Heegaard,et al. Conformational Intermediate of the Amyloidogenic Protein β2-Microglobulin at Neutral pH* , 2001, The Journal of Biological Chemistry.
[87] V. Uversky,et al. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. , 2001, Biochemistry.
[88] H. M. Petrassi,et al. An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. , 2001, Biochemistry.
[89] V. Uversky,et al. Denatured collapsed states in protein folding: Example of apomyoglobin , 2001, Proteins.
[90] R. Wetzel,et al. Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. , 2001, Journal of molecular biology.
[91] J. Johansson. Membrane properties and amyloid fibril formation of lung surfactant protein C. , 2001, Biochemical Society transactions.
[92] V. Uversky,et al. Pesticides directly accelerate the rate of α‐synuclein fibril formation: a possible factor in Parkinson's disease , 2001, FEBS letters.
[93] B. Bevis,et al. The assembly of amyloidogenic yeast sup35 as assessed by scanning (atomic) force microscopy: an analogy to linear colloidal aggregation? , 2001, Biophysical journal.
[94] G. Vriend,et al. Amyloid‐like fibrils from an 18‐residue peptide analogue of a part of the central domain of the B‐family of silkmoth chorion proteins , 2001, FEBS letters.
[95] V. Uversky,et al. Probing the mechanism of insulin fibril formation with insulin mutants. , 2001, Biochemistry.
[96] M. Saraiva. Transthyretin amyloidosis: a tale of weak interactions , 2001, FEBS letters.
[97] M. Goedert. The significance of tau and α-synuclein inclusions in neurodegenerative diseases , 2001 .
[98] G. Howlett,et al. NMR structure of human apolipoprotein C-II in the presence of sodium dodecyl sulfate. , 2001, Biochemistry.
[99] P E Fraser,et al. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis. , 2001, Journal of molecular biology.
[100] K. Fischbeck,et al. Polyglutamine and CBP: Fatal attraction? , 2001, Nature Medicine.
[101] C. Dobson,et al. Amyloid fibril formation by a helical cytochrome , 2001, FEBS letters.
[102] Michel Goedert,et al. Parkinsons Disease and other α-Synucleinopathies , 2001 .
[103] V. Uversky,et al. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. , 2001, Biochemistry.
[104] G. Howlett,et al. Sub‐micellar phospholipid accelerates amyloid formation by apolipoprotein C‐II , 2001, FEBS letters.
[105] V. Uversky,et al. Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation* , 2001, The Journal of Biological Chemistry.
[106] C. Dobson,et al. Reduction of the amyloidogenicity of a protein by specific binding of ligands to the native conformation , 2001, Protein science : a publication of the Protein Society.
[107] Christopher M. Dobson,et al. Amyloid fibrils from muscle myoglobin , 2001, Nature.
[108] C. Ionescu-Zanetti,et al. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. , 2001, Biochemistry.
[109] C. Dobson. The structural basis of protein folding and its links with human disease. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[110] A. Komar,et al. Stability, folding, dimerization, and assembly properties of the yeast prion Ure2p. , 2001, Biochemistry.
[111] G. Asano,et al. α-Synuclein-positive structures in cases with sporadic Alzheimer’s disease: morphology and its relationship to tau aggregation , 2001, Brain Research.
[112] D. Selkoe,et al. A de novo designed helix-turn-helix peptide forms nontoxic amyloid fibrils , 2000, Nature Structural Biology.
[113] P. Lansbury,et al. Accelerated Oligomerization by Parkinson's Disease Linked α‐Synuclein Mutants , 2000 .
[114] V. Uversky,et al. Why are “natively unfolded” proteins unstructured under physiologic conditions? , 2000, Proteins.
[115] F. Cohen,et al. Identification of the Cu2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy. , 2000, Biochemistry.
[116] T. Fath,et al. Structural and functional implications of tau hyperphosphorylation: information from phosphorylation-mimicking mutated tau proteins. , 2000, Biochemistry.
[117] E. Wanker. Protein Aggregation and Pathogenesis of Huntingtons Disease: Mechanisms and Correlations , 2000, Biological chemistry.
[118] K. Fischbeck,et al. CREB-binding protein sequestration by expanded polyglutamine. , 2000, Human molecular genetics.
[119] S. Lindquist,et al. Nucleated conformational conversion and the replication of conformational information by a prion determinant. , 2000, Science.
[120] A. Doig,et al. Is polyproline II helix the killer conformation? A Raman optical activity study of the amyloidogenic prefibrillar intermediate of human lysozyme. , 2000, Journal of molecular biology.
[121] A. Koide,et al. Solution conformation and amyloid-like fibril formation of a polar peptide derived from a beta-hairpin in the OspA single-layer beta-sheet. , 2000, Journal of molecular biology.
[122] S. Radford,et al. Partially unfolded states of beta(2)-microglobulin and amyloid formation in vitro. , 2000, Biochemistry.
[123] L. Regan,et al. A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[124] L. Serpell,et al. The protofilament substructure of amyloid fibrils. , 2000, Journal of molecular biology.
[125] C M Dobson,et al. Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain. , 2000, Journal of molecular biology.
[126] C. MacPhee,et al. Human apolipoprotein C-II forms twisted amyloid ribbons and closed loops. , 2000, Biochemistry.
[127] U Aebi,et al. Amyloid fibril formation from full-length and fragments of amylin. , 2000, Journal of structural biology.
[128] R. Crowther,et al. Abnormal tau-containing filaments in neurodegenerative diseases. , 2000, Journal of structural biology.
[129] Kang Hu,et al. High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.
[130] G. Merlini,et al. Review: immunoglobulin light chain amyloidosis--the archetype of structural and pathogenic variability. , 2000, Journal of structural biology.
[131] C. Dobson,et al. Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants. , 2000, Journal of structural biology.
[132] L. Berliner,et al. α‐Lactalbumin: structure and function , 2000 .
[133] H. Fabian,et al. Conversion of yeast phosphoglycerate kinase into amyloid‐like structure , 2000, Proteins.
[134] C. Dobson,et al. Biophysical studies of the development of amyloid fibrils from a peptide fragment of cold shock protein B. , 2000, European journal of biochemistry.
[135] C. Cotman,et al. Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to Alzheimer’ β amyloid peptide , 2000 .
[136] C M Dobson,et al. Mutational analysis of the propensity for amyloid formation by a globular protein , 2000, The EMBO journal.
[137] James C. Sacchettini,et al. Rational design of potent human transthyretin amyloid disease inhibitors , 2000, Nature Structural Biology.
[138] H. Zoghbi,et al. Fourteen and counting: unraveling trinucleotide repeat diseases. , 2000, Human molecular genetics.
[139] P E Fraser,et al. Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid‐like fibrils , 2000, FEBS letters.
[140] K. Namba,et al. The process of amyloid-like fibril formation by methionine aminopeptidase from a hyperthermophile, Pyrococcus furiosus. , 2000, Biochemistry.
[141] L. Mucke,et al. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. , 2000, Science.
[142] G. Arlaud,et al. A peptide from the adenovirus fiber shaft forms amyloid‐type fibrils , 2000, FEBS letters.
[143] P. Lansbury,et al. Amyloid fibrillogenesis: themes and variations. , 2000, Current opinion in structural biology.
[144] M. Manning,et al. Thermodynamic Modulation of Light Chain Amyloid Fibril Formation* , 2000, The Journal of Biological Chemistry.
[145] P. Lansbury,et al. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[146] C. Ionescu-Zanetti,et al. Monitoring the assembly of Ig light-chain amyloid fibrils by atomic force microscopy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[147] S Doniach,et al. Natively unfolded human prothymosin alpha adopts partially folded collapsed conformation at acidic pH. , 1999, Biochemistry.
[148] V. Uversky,et al. Protein deposits as the molecular basis of amyloidosis. Part II . Localizated amyloidosis and neurodegenerative disorders , 1999 .
[149] H. Dyson,et al. Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. , 1999, Journal of molecular biology.
[150] H. Zoghbi,et al. Polyglutamine diseases: protein cleavage and aggregation , 1999, Current Opinion in Neurobiology.
[151] M. Schell,et al. Thermodynamic instability of human lambda 6 light chains: correlation with fibrillogenicity. , 1999, Biochemistry.
[152] M. Hecht,et al. De novo amyloid proteins from designed combinatorial libraries. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[153] C. Wurth,et al. The most pathogenic transthyretin variant, L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditions. , 1999, Biochemistry.
[154] A. Alexandrescu,et al. An NMR investigation of solution aggregation reactions preceding the misassembly of acid-denatured cold shock protein A into fibrils. , 1999, Journal of molecular biology.
[155] C. Dobson. Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.
[156] J. Collinge,et al. Structural mobility of the human prion protein probed by backbone hydrogen exchange , 1999, Nature Structural Biology.
[157] K. Murata,et al. Amyloid‐like aggregates of a plant protein: a case of a sweet‐tasting protein, monellin , 1999, FEBS letters.
[158] D. Housman,et al. Evidence for a recruitment and sequestration mechanism in Huntington's disease. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[159] R. Seckler,et al. Formation of Fibrous Aggregates from a Non-native Intermediate: The Isolated P22 Tailspike β-Helix Domain* , 1999, The Journal of Biological Chemistry.
[160] R. Glockshuber,et al. Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates , 1999, Nature Structural Biology.
[161] V. Bellotti,et al. Biological activity and pathological implications of misfolded proteins , 1999, Cellular and Molecular Life Sciences CMLS.
[162] A. Komar,et al. Structural Characterization of Saccharomyces cerevisiae Prion-like Protein Ure2* , 1999, The Journal of Biological Chemistry.
[163] C. Redfield. Molten globules , 1999, Current Biology.
[164] C. Dobson,et al. Mechanistic studies of the folding of human lysozyme and the origin of amyloidogenic behavior in its disease-related variants. , 1999, Biochemistry.
[165] J. Bernhagen,et al. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. , 1999, Journal of molecular biology.
[166] M. Citron,et al. Both Familial Parkinson’s Disease Mutations Accelerate α-Synuclein Aggregation* , 1999, The Journal of Biological Chemistry.
[167] C M Dobson,et al. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[168] P. Lansbury. Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[169] Elena Orlova,et al. Cryo‐electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing , 1999, The EMBO journal.
[170] P. Tucker,et al. The glutamine-rich domain of the Drosophila GAGA factor is necessary for amyloid fibre formation in vitro, but not for chromatin remodelling. , 1999, Journal of molecular biology.
[171] J. Kelly,et al. Synthesis and evaluation of anthranilic acid-based transthyretin amyloid fibril inhibitors. , 1999, Bioorganic & medicinal chemistry letters.
[172] V. Uversky,et al. Hyperphosphorylation induces structural modification of tau‐protein , 1998, FEBS letters.
[173] Peter T. Lansbury,et al. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease , 1998, Nature Medicine.
[174] Scott A. Peterson,et al. Inhibiting transthyretin conformational changes that lead to amyloid fibril formation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[175] Scott A. Peterson,et al. Discovering transthyretin amyloid fibril inhibitors by limited screening. , 1998, Bioorganic & medicinal chemistry.
[176] S. Aota,et al. Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module. , 1998, Journal of molecular biology.
[177] T. Yamazaki,et al. Solution structure of thermostable cytochrome c-552 from Hydrogenobacter thermophilus determined by 1H-NMR spectroscopy. , 1998, Biochemistry.
[178] B. W. Erickson,et al. Engineering of betabellin‐15d: A 64 residue beta sheet protein that forms long narrow multimeric fibrils , 1998, Protein science : a publication of the Protein Society.
[179] J. Weissman,et al. A Critical Role for Amino-Terminal Glutamine/Asparagine Repeats in the Formation and Propagation of a Yeast Prion , 1998, Cell.
[180] D. Teplow,et al. Structural and kinetic features of amyloid beta-protein fibrillogenesis. , 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[181] V. Uversky,et al. Anion-induced folding of Staphylococcal nuclease: characterization of multiple equilibrium partially folded intermediates. , 1998, Journal of molecular biology.
[182] I D Campbell,et al. Amyloid fibril formation by an SH3 domain. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[183] C. Dobson,et al. Conformational stability of muscle acylphosphatase: the role of temperature, denaturant concentration, and pH. , 1998, Biochemistry.
[184] J. Kelly,et al. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. , 1998, Current opinion in structural biology.
[185] A. Fink. Protein aggregation: folding aggregates, inclusion bodies and amyloid. , 1998, Folding & design.
[186] P. Lansbury,et al. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. , 1997, Chemistry & biology.
[187] V. Uversky,et al. Sequential Compaction of a Random Copolymer of Hydrophilic and Hydrophobic Amino Acid Residues , 1997 .
[188] V. Uversky. Diversity of equilibrium compact forms of denatured globular proteins , 1997, Protein & Peptide Letters.
[189] R. Wickner,et al. The prion model for [URE3] of yeast: spontaneous generation and requirements for propagation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[190] L. Serpell,et al. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. , 1997, Journal of molecular biology.
[191] E. Stellwagen,et al. The role of PII conformations in the calculation of peptide fractional helix content , 1997, Protein science : a publication of the Protein Society.
[192] M. Jadoul,et al. Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study. , 1997, Kidney international.
[193] S. Lindquist,et al. Self-Seeded Fibers Formed by Sup35, the Protein Determinant of [PSI +], a Heritable Prion-like Factor of S. cerevisiae , 1997, Cell.
[194] S. Lindquist,et al. Mad Cows Meet Psi-chotic Yeast: The Expansion of the Prion Hypothesis , 1997, Cell.
[195] J. Brange,et al. Toward understanding insulin fibrillation. , 1997, Journal of pharmaceutical sciences.
[196] M. Billingsley,et al. Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. , 1997, The Biochemical journal.
[197] S. Radford,et al. Responsive gels formed by the spontaneous self-assembly of peptides into polymeric β-sheet tapes , 1997, Nature.
[198] D. Selkoe,et al. Alzheimer's Disease--Genotypes, Phenotype, and Treatments , 1997, Science.
[199] P. Nordlund,et al. Crystal structure of common type acylphosphatase from bovine testis. , 1997, Structure.
[200] P. Lansbury,et al. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. , 1996, Biochemistry.
[201] L. Barron,et al. Residual structure in unfolded proteins revealed by Raman optical activity. , 1996, Biochemistry.
[202] Tracy M. Handel,et al. Detection of rare partially folded molecules in equilibrium with the native conformation of RNaseH , 1996, Nature Structural Biology.
[203] J R Glover,et al. Support for the Prion Hypothesis for Inheritance of a Phenotypic Trait in Yeast , 1996, Science.
[204] R. Riek,et al. NMR structure of the mouse prion protein domain PrP(121–231) , 1996, Nature.
[205] Alejandra del C. Alonso,et al. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules , 1996, Nature Medicine.
[206] S. Paushkin,et al. Propagation of the yeast prion‐like [psi+] determinant is mediated by oligomerization of the SUP35‐encoded polypeptide chain release factor. , 1996, The EMBO journal.
[207] J. Kelly,et al. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. , 1996, Biochemistry.
[208] J. Kelly,et al. Alternative conformations of amyloidogenic proteins govern their behavior. , 1996, Current opinion in structural biology.
[209] O. Ptitsyn,et al. Further evidence on the equilibrium "pre-molten globule state": four-state guanidinium chloride-induced unfolding of carbonic anhydrase B at low temperature. , 1996, Journal of molecular biology.
[210] G. Damaschun,et al. Prothymosin alpha: a biologically active protein with random coil conformation. , 1995, Biochemistry.
[211] R. Wickner,et al. Prion-Inducing Domain of Yeast Ure2p and Protease Resistance of Ure2p in Prion-Containing Cells , 1995, Science.
[212] K. Titani,et al. Hyperphosphorylation of Tau in PHF , 1995, Neurobiology of Aging.
[213] O. Ptitsyn,et al. Kinetic and equilibrium folding intermediates. , 1995, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[214] K. Titani,et al. Proline-directed and Non-proline-directed Phosphorylation of PHF-tau (*) , 1995, The Journal of Biological Chemistry.
[215] Abnormally phosphorylated tau from Alzheimer disease brain depolymerizes microtubules A. del C. Alonso, I. Grundke-Iqbal and K. Iqbal. New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York 10314 USA , 1994, Neurobiology of Aging.
[216] C. Dobson,et al. Equilibrium unfolding studies of horse muscle acylphosphatase. , 1994, European journal of biochemistry.
[217] E. Mandelkow,et al. Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure. , 1994, The Journal of biological chemistry.
[218] C. Colaco,et al. Amyloid fibril formation , 1994, Bio/Technology.
[219] G. Marhaug,et al. Serum amyloid A: an acute phase apolipoprotein and precursor of AA amyloid. , 1994, Bailliere's clinical rheumatology.
[220] I. Grundke‐Iqbal,et al. Alzheimer paired helical filaments Restoration of the biological activity by dephosphorylation , 1994, FEBS letters.
[221] P. Limburg,et al. Rapid automated enzyme immunoassay of serum amyloid A. , 1994, Clinical chemistry.
[222] M. Hurle,et al. A role for destabilizing amino acid replacements in light-chain amyloidosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[223] Khadija Iqbal,et al. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[224] R. Wickner,et al. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. , 1994, Science.
[225] O. Ptitsyn,et al. "Partly folded" state, a new equilibrium state of protein molecules: four-state guanidinium chloride-induced unfolding of beta-lactamase at low temperature. , 1994, Biochemistry.
[226] M. Williamson,et al. The structure and function of proline-rich regions in proteins. , 1994, The Biochemical journal.
[227] K. Titani,et al. In vivo phosphorylation sites in fetal and adult rat tau. , 1993, The Journal of biological chemistry.
[228] S. Yen,et al. The extent of phosphorylation of fetal tau is comparable to that of PHF-tau from Alzheimer paired helical filaments , 1993, Brain Research.
[229] R. Brandt,et al. The Balance Between τ Protein's Microtubule Growth and Nucleation Activities: Implications for the Formation of Axonal Microtubules , 1993, Journal of neurochemistry.
[230] D. Brems,et al. Acid stabilization of insulin. , 1993, Biochemistry.
[231] I. Campbell,et al. Solution structure and ligand-binding site of the SH3 domain of the p85α subunit of phosphatidylinositol 3-kinase , 1993, Cell.
[232] D. Booth,et al. Human lysozyme gene mutations cause hereditary systemic amyloidosis , 1993, Nature.
[233] R. Brandt,et al. Functional organization of microtubule-associated protein tau. Identification of regions which affect microtubule growth, nucleation, and bundle formation in vitro. , 1993, The Journal of biological chemistry.
[234] J. Wood,et al. Functional studies of Alzheimer's disease tau protein , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[235] M. Sternberg,et al. Left-handed polyproline II helices commonly occur in globular proteins. , 1993, Journal of molecular biology.
[236] R. Braun,et al. Proline-directed phosphorylation of human Tau protein. , 1992, The Journal of biological chemistry.
[237] J. R. Somoza,et al. 1H resonance assignments, secondary structure and general topology of single-chain monellin in solution as determined by1H 2D-NMR , 1992, Journal of biomolecular NMR.
[238] A. Hyman,et al. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. , 1992, Molecular biology of the cell.
[239] J. Buxbaum. Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease. , 1992, Hematology/oncology clinics of North America.
[240] R J Williams,et al. Three-dimensional structure of acylphosphatase. Refinement and structure analysis. , 1992, Journal of molecular biology.
[241] T. Keiderling,et al. Reassessment of the random coil conformation: Vibrational CD study of proline oligopeptides and related polypeptides , 1991, Biopolymers.
[242] J. Tamada,et al. Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[243] J. Bartek,et al. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. , 1991, Oncogene.
[244] K. Sletten,et al. Fibril in senile systemic amyloidosis is derived from normal transthyretin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[245] M. Karplus,et al. Two-dimensional NMR and photo-CIDNP studies of the insulin monomer: assignment of aromatic resonances with application to protein folding, structure, and dynamics. , 1989, Biochemistry.
[246] E. Mandelkow,et al. Tau protein becomes long and stiff upon phosphorylation: correlation between paracrystalline structure and degree of phosphorylation , 1989, The Journal of cell biology.
[247] R. J. Williams,et al. The sequence-specific assignment of the 1H-NMR spectrum of an enzyme, horse-muscle acylphosphatase. , 1989, European journal of biochemistry.
[248] R. J. Williams,et al. Identification and description of beta-structure in horse muscle acylphosphatase by nuclear magnetic resonance spectroscopy. , 1989, Journal of molecular biology.
[249] A. Himmler. Structure of the bovine tau gene: alternatively spliced transcripts generate a protein family , 1989, Molecular and cellular biology.
[250] R. J. Williams,et al. Identification and description of alpha-helical regions in horse muscle acylphosphatase by 1H nuclear magnetic resonance spectroscopy. , 1989, Journal of molecular biology.
[251] V. Saudek,et al. The structure and properties of horse muscle acylphosphatase in solution Mobility of antigenic and active site regions , 1989, FEBS letters.
[252] C. Kay,et al. Circular-dichroism studies on two murine serum amyloid A proteins. , 1988, The Biochemical journal.
[253] R. Turner,et al. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[254] M. A. Saper,et al. Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.
[255] D. W. Hayden,et al. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[256] A. Frankfurter,et al. The distribution of tau in the mammalian central nervous system , 1985, The Journal of cell biology.
[257] G. Reeke,et al. Three-dimensional structure of beta 2-microglobulin. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[258] M. Saraiva,et al. Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). , 1984, The Journal of clinical investigation.
[259] N. Kallenbach,et al. Hydrogen exchange and structural dynamics of proteins and nucleic acids , 1983, Quarterly Reviews of Biophysics.
[260] E. Wilander,et al. Islet amyloid in type 2 (non-insulin-dependent) diabetes is related to insulin , 1983, Diabetologia.
[261] H. Watson,et al. Sequence and structure of yeast phosphoglycerate kinase. , 1982, The EMBO journal.
[262] G. Ramponi,et al. Hydrolysis by horse muscle acylphosphatase of (Ca2+ + Mg2+)-ATPase phosphorylated intermediate. , 1981, Archives of biochemistry and biophysics.
[263] Akira Okano,et al. Amyloid fibril protein in familial amyloid polyneuropathy , 1981, Neurology.
[264] M. Kirschner,et al. Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. , 1977, Journal of molecular biology.
[265] M. Kirschner,et al. Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. , 1977, Journal of molecular biology.
[266] M. Benson,et al. Fibrillar assemblage of variable segments of immunoglobulin light chains: an electron microscopic study. , 1973, Journal of immunology.
[267] T. Blundell,et al. Three-Dimensional Atomic Structure of Insulin and Its Relationship to Activity , 1972, Diabetes.
[268] A. Cohen,et al. HIGH-RESOLUTION ELECTRON MICROSCOPIC ANALYSIS OF THE AMYLOID FIBRIL , 1967, The Journal of cell biology.
[269] L. Hokin,et al. Evidence that a phosphorylated intermediate in a brain transport adenosine triphosphatase is an acyl phosphate. , 1965, Proceedings of the National Academy of Sciences of the United States of America.
[270] D. F. Waugh,et al. Studies of the Nucleation and Growth Reactions of Selected Types of Insulin Fibrils , 1953 .
[271] D. F. Waugh. A Fibrous Modification of Insulin. I. The Heat Precipitate of Insulin , 1946 .
[272] D. Wiley,et al. Structure of the human class I histocompatibility antigen, HLA-A2. , 2005, Journal of immunology.
[273] V. Uversky,et al. Nitration inhibits fibrillation of human alpha-synuclein in vitro by formation of soluble oligomers. , 2003, FEBS letters.
[274] V. Uversky,et al. Biophysical constraints for protein structure prediction. , 2003, Journal of proteome research.
[275] C. Dobson,et al. A kinetic study of beta-lactoglobulin amyloid fibril formation promoted by urea. , 2002, Protein science : a publication of the Protein Society.
[276] V. Subramaniam,et al. Amyloid fibrils from the mammalian protein prothymosin alpha. , 2002, FEBS letters.
[277] V. Uversky,et al. Conformational prerequisites for alpha-lactalbumin fibrillation. , 2002, Biochemistry.
[278] Kiowa S. Bower,et al. Accelerated alpha-synuclein fibrillation in crowded milieu. , 2002, FEBS letters.
[279] Vladimir N Uversky,et al. What does it mean to be natively unfolded? , 2002, European journal of biochemistry.
[280] G. Rose. Getting to know u. , 2002, Advances in protein chemistry.
[281] R. Ribeiro,et al. A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer , 2002, Nature Structural Biology.
[282] Robert W Woody,et al. Is polyproline II a major backbone conformation in unfolded proteins? , 2002, Advances in protein chemistry.
[283] M. Hoshino,et al. Mapping the core of the beta(2)-microglobulin amyloid fibril by H/D exchange. , 2002, Nature structural biology.
[284] J. Trojanowski,et al. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. , 2002, Neuron.
[285] V. Uversky,et al. Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro. , 2002, FEBS letters.
[286] L. Barron,et al. Unfolded proteins studied by Raman optical activity. , 2002, Advances in protein chemistry.
[287] Z. Obradovic,et al. Identification and functions of usefully disordered proteins. , 2002, Advances in protein chemistry.
[288] W. Mcdougal. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. , 2002, The Journal of urology.
[289] Brigida Bochicchio,et al. Polyproline II structure in proteins: identification by chiroptical spectroscopies, stability, and functions. , 2002, Chirality.
[290] V. Uversky,et al. The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. , 2002, The Journal of biological chemistry.
[291] S. Radford,et al. Structural properties of an amyloid precursor of beta(2)-microglobulin. , 2002, Nature structural biology.
[292] Ewan W Blanch,et al. A Raman optical activity study of rheomorphism in caseins, synucleins and tau. New insight into the structure and behaviour of natively unfolded proteins. , 2002, European journal of biochemistry.
[293] E. Žerovnik,et al. Amyloid-fibril formation. Proposed mechanisms and relevance to conformational disease. , 2002, European journal of biochemistry.
[294] D. Price,et al. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[295] A Keith Dunker,et al. Intrinsic disorder and protein function. , 2002, Biochemistry.
[296] M. Goedert. Parkinson's disease and other alpha-synucleinopathies. , 2001, Clinical chemistry and laboratory medicine.
[297] M. Goedert. The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases. , 2001, Current opinion in genetics & development.
[298] J. Collinge. Prion diseases of humans and animals: their causes and molecular basis. , 2001, Annual review of neuroscience.
[299] V. Uversky,et al. Trimethylamine-N-oxide-induced folding of alpha-synuclein. , 2001, FEBS letters.
[300] Christopher J. Oldfield,et al. Intrinsically disordered protein. , 2001, Journal of molecular graphics & modelling.
[301] N. Heegaard,et al. Conformational Intermediate of the Amyloidogenic Protein (cid:1) 2 -Microglobulin at Neutral pH* , 2001 .
[302] C. Cotman,et al. Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer's A beta peptide. , 2000, Biochemistry.
[303] L. Berliner,et al. alpha-Lactalbumin: structure and function. , 2000, FEBS letters.
[304] H. Zoghbi,et al. Trinucleotide repeats: mechanisms and pathophysiology. , 2000, Annual review of genomics and human genetics.
[305] P. Lansbury,et al. Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants. , 2000, Annals of the New York Academy of Sciences.
[306] C. Dobson,et al. Formation of amyloid fibrils by peptides derived from the bacterial cold shock protein CspB , 1999, Protein science : a publication of the Protein Society.
[307] C. Murphy,et al. In vitro immunoglobulin light chain fibrillogenesis. , 1999, Methods in enzymology.
[308] S. Lindquist,et al. [PSI+]: an epigenetic modulator of translation termination efficiency. , 1999, Annual review of cell and developmental biology.
[309] S. Lindquist,et al. Yeast prion [psi +] and its determinant, Sup35p. , 1999, Methods in enzymology.
[310] A. Delacourte,et al. Normal and pathological Tau proteins as factors for microtubule assembly. , 1997, International review of cytology.
[311] R. Wetzel. Domain stability in immunoglobulin light chain deposition disorders. , 1997, Advances in protein chemistry.
[312] A. Arabshahi,et al. [6] Second virial coefficient as predictor in protein crystal growth. , 1997, Methods in enzymology.
[313] O. Ptitsyn,et al. Molten globule and protein folding. , 1995, Advances in protein chemistry.
[314] A. Fink. Compact intermediate states in protein folding. , 1995, Annual review of biophysics and biomolecular structure.
[315] H. Taguchi,et al. [Molecular chaperone]. , 1994, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[316] I. Campbell,et al. Solution structure and ligand-binding site of the SH3 domain of the p85 alpha subunit of phosphatidylinositol 3-kinase. , 1993, Cell.
[317] A. Gown,et al. Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue. , 1992, The American journal of pathology.
[318] T. Blundell,et al. The crystal structure of rhombohedral 2 zinc insulin. , 1972, Cold Spring Harbor symposia on quantitative biology.
[319] J. Ehrlich,et al. Amyloidosis of the islets of Langerhans. A restudy of islet hyalin in diabetic and non-diabetic individuals. , 1961, The American journal of pathology.
[320] A. J. Clifford,et al. BIOCHIMICA ET BIOPHYSICA ACTA , 2022 .